期刊文献+

低分子肝素治疗博来霉素诱导大鼠肺纤维化的研究 被引量:4

原文传递
导出
摘要 肺间质纤维化过程中凝血系统出现异常变化,纤维蛋白溶解活性下降。低分子肝素是临床常用的抗凝血药,并有促使纤溶酶原释放,使纤溶酶原激活物抑制物-1(PAI-1)和纤维蛋白原的浓度降低的作用。为此,我们观察了低分子肝素对大鼠肺间质纤维化的治疗效果及其可能的作用机制。
出处 《中华结核和呼吸杂志》 CAS CSCD 北大核心 2009年第5期384-385,共2页 Chinese Journal of Tuberculosis and Respiratory Diseases
  • 相关文献

参考文献8

  • 1Idell S, James KK, Gillies C, et al. Abnormalities of pathways of fibrin turnover in lung lavage of rats with oleic acid and bleomycin- induced lung injury support alveolar fibrin deposition. Am J Pathol, 1989,135:387-399.
  • 2Frampton JE, Faulds D. Parnaparin. A review of its pharmacology, and clinical application in the prevention and treatment of thromboembolic and other vascular disorders. Drugs, 1994, 47:652-676.
  • 3Szapiel SV, Elson NA, Fulmer JD, et al. Bleomycin-induced interstitial pulmonary disease in the nude, athymic mouse. Am Rev Respir Dis, 1979,120 : 893-899.
  • 4吴仁毅,姚克,叶娟,徐雯,孙朝晖,申屠形超.低相对分子质量肝素对牛晶状体上皮细胞在人工晶状体表面增殖的影响[J].中华眼科杂志,2002,38(11):688-690. 被引量:8
  • 5Baram D, Rashkovsky M, Hershkoviz R, et al. Inhibitory effects of low molecular weight heparin on mediator release by mast cells : preferential inhibition of cytokine production and mast cell- dependent cutaneous inflammation. Clin Exp Immunol, 1997, 110:485-491.
  • 6Yard BA, Chorianopoulos E, Herr D, et al. Regulation of endothelin-1 and transforming growth factor-betal production in cultured proximal tubular cells by albumin and heparan sulphate glycosaminoglycans. Nephrol Dial Transplant, 2001, 16: 1769- 1775.
  • 7Zhao Z, Tan Z, Diltz CD, et al. Activation of mitogen-activated protein (MAP) kinase pathway by pervanadate, a potent inhibitor of tyrosine phosphatases. J Biol Chem, 1996,271:22251-22255.
  • 8Eitzman DT, McCoy RD, Zheng X, et al. Bleomycin-induced pulmonary fibrosis in transgenic mice that either lack or overexpress the murine plasminogen activator inhibitor-1 gene. J Clin Invest, 1996,97:232-237.

二级参考文献5

共引文献7

同被引文献63

  • 1刘永琦,李金田,李娟,张毅,颜春鲁,杨军,宋华平.黄芪对肺纤维化大鼠Th1/Th2型细胞因子平衡及自由基代谢的影响[J].免疫学杂志,2009,25(3):290-292. 被引量:45
  • 2徐兴祥,朱元珏.特发性肺纤维化治疗的研究进展[J].国外医学(呼吸系统分册),2004,24(3):146-149. 被引量:5
  • 3侯杰.特发性肺纤维化[J].中国厂矿医学,2005,18(3):193-194. 被引量:6
  • 4Nicholson AG,Fulford LG,Colby TV,et al.The relationship between individual histologic features and disease progression in idiopathic pulmonary fibrosis.Am J Respir Crit Care Med,2002,166:173-177.
  • 5Kuwano K,Nakashima N,Inoshima I,et al.Oxidative stress in lung epithelial cells from patients with idiopathic interstitial pneumonias.Eur Respir J,2003,21:232 240.
  • 6Selman M,Thannickal VJ,Pardo A,et al.Idiopathic pulmonary fibrosis:pathogenesis and therapeutic approaches.Drugs,2004,64:405-430.
  • 7Raghu G,Depaso WJ,Cain K,et al.Azathioprine combined with prednisone in the treatment of idiopathic pulmonary fibrosis:a prospective double-blind,randomized,placebocontrolled clinical trial.Am Rev Respir Dis,1991,144:291-296.
  • 8Flaherty KR,Toews GB,Lynch JP 3rd,et al.Steroids in idiopathic pulmonary fibrosis:a prospective assessment of adverse reactions,response to therapy,and survival.Am J Med,2001,110:278-282.
  • 9Tengstrand B,Ernestam S,Engvall IL,et al.TNF blockade in rheumatoid arthritis can cause severe fibrosing alveolitis.Six case reports.Lakartidningen,2005,102:3788-3790,3793.
  • 10Saracco P, Vitale P, Scolfaro C, et al. The coagulopathy in sepsis: significance and implications for treatment[J]. Pedi- atr Rep, 2011, 30, 3(4): 30.

引证文献4

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部